Koning Health Email Formats

Medical Equipment Manufacturing • Norcross, Georgia, United States • 21-50 Employees

Koning Health Email Formats

Koning Health uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@koninghealth.com), used 70% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@koninghealth.com	70%
{first initial}{last name}	jdoe@koninghealth.com	20%
{first name}.{last name}	john.doe@koninghealth.com	10%

Key Contacts at Koning Health

Xiaohua Zhang

Director Of Clinical Affairs

Christopher Costa

Director Of Operations And Development

Shaohua Liu

Director Of Research And Development, Imaging Scientist

Company overview

Headquarters	5555 Oakbrook Parkway, Suite 640, Norcross, GA 30093, US
Phone number	+15852142459
Websites	koninghealth.com koningcorporation.com
NAICS	3391
SIC	384
Keywords	Medical Devices, Medical Imaging, Breast Cancer, Breast Cancer Detection, 3D Computed Tomography
Employees	21-50
Socials

About Koning Health

Koning Corporation develops and manufactures advanced medical imaging systems for breast cancer detection using cone-beam computed tomography technology. This revolutionary technology provides true 3D images for early breast cancer detection, providing a significantly more accurate and effective test than mammography and tomosynthesis. Koning's vision is to fundamentally change breast cancer is detected and diagnosed, with earlier detection, increased patient comfort and lower costs. We believe our Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. We believe that the power, versatility and lower cost of Koning Breast CT will serve as a viable substitute for many traditional imaging applications. Our hope is to be able to improve survival rates and outcomes for millions of patients. Koning Corporation's core technologies are protected by over 80 patents globally, and has received regulatory approval in the US (FDA), Europe (CE-Mark), China (CFDA), Australia (TPG), and Canada (Health Canada). Koning has been the beneficiary of over $17 M in venture funding and over $20 M in government grants to bring this exciting technology to market. Future versions of our technology are expected to optimize early disease detection, diagnosis, intervention and treatment in numerous areas of the body.